JPRN-UMIN000013543已完成未知
The effect of olmesartan on hypertensive cardiac remodeling - The effect of olmesartan on hypertensive cardiac remodeling
ational Defense Medical College0 个研究点目标入组 30 人开始时间: 2014年3月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
This trial was terminated for the reason that enough number of patients could not be recruited.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The patients whose (a) age <20 or >79, (b) prohibited to MRI, (c) expected high probability of the side-effect of ormethaltan, (d) ejection fraction <40%, (d) patients regarded as inappropriate for the study by doctor.
研究者
相似试验
已完成
不适用
Efficacy and safety of statin treatment for hypercholesterolemia with chronic liver diseasechronic liver diseaseJPRN-UMIN000002011The Jikei University School of Medicine, Kashiwa Hospital50
招募中
4 期
Toyama antihypertensive therapy with Olmesartan in Post-Stroke patients (TOPS) studyHypertension, Post-strokeJPRN-UMIN000009790niversity of Toyama100
已完成
3 期
Olmesartan in Essential HypertensionEssential HypertensionNCT00185172Sankyo Pharma Gmbh2,333
已完成
3 期
Telmisartan 80mg Non-responder TrialHypertensionNCT01222520Boehringer Ingelheim174
已完成
不适用
Stopping Antihypertensive Treatment amOng Hypertensive Patients in Primary Care (STOP-Trial)HypertensionNCT02268071Central Hospital, Nancy, France403